Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells

Author： Qu Ying   Wang Jinhua   Sim Myung-Shin   Liu Bingya   Giuliano Armando   Barsoum James   Cui Xiaojiang  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.121, Iss.2, 2010-06, pp. : 311-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose-dependent effect of tamoxifen in tamoxifen-resistant breast cancer cells via stimulation by the ERK1/2 and AKT signaling pathways

By                  

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1563-1569

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of apoptotic signaling pathways in cancer cells as a mechanism of chemotherapy resistance

By Haq R.   Zanke B.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 233-239

Springer Publishing Company

Access to resources Recommend Favorite

Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2

By          

International Journal of Oncology, Vol. 44, Iss. 5, 2014-01 ,pp. : 1707-1715

Spandidos Publications

Access to resources Recommend Favorite

Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells

By    

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 819-825

Spandidos Publications

Access to resources Recommend Favorite

Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells

By                

Oncology Reports, Vol. 30, Iss. 4, 2013-01 ,pp. : 1913-1919

Spandidos Publications

Access to resources Recommend Favorite